A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies (Q37036934)

17 August 2017

A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies (English)

1 reference

multicenter clinical trial

17 August 2017

phase II clinical trial

0 references

0 references

author name string

Morris D Groves

1

1 reference

17 August 2017

Michael J Glantz

2

1 reference

17 August 2017

Marc C Chamberlain

3

1 reference

17 August 2017

Karen E Baumgartner

4

1 reference

17 August 2017

Charles A Conrad

5

1 reference

17 August 2017

Sigmund Hsu

6

1 reference

17 August 2017

Jeffrey S Wefel

7

1 reference

17 August 2017

Mark R Gilbert

8

1 reference

17 August 2017

Sandra Ictech

9

1 reference

17 August 2017

Kathy U Hunter

10

1 reference

17 August 2017

Arthur D Forman

11

1 reference

17 August 2017

Vinay K Puduvalli

12

1 reference

17 August 2017

Howard Colman

13

1 reference

17 August 2017

Kenneth R Hess

14

1 reference

17 August 2017

W K Alfred Yung

15

1 reference

17 August 2017

3 March 2008

1 reference

17 August 2017

1 reference

17 August 2017

10

1 reference

17 August 2017

2

1 reference

17 August 2017

208-215

1 reference

Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613823

Cytotoxic activity of topotecan in human tumour cell lines and primary cultures of human tumour cells from patients

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613823

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613823

Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613823

Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613823

Update on planning of phase II clinical trials

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613823

Meningeal carcinomatosis from breast cancer: spinal cord vs. brain involvement

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613823

Leptomeningeal carcinomatosis. Presenting features and prognostic factors.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613823

Combined intraommaya methotrexate, cytosine arabinoside, hydrocortisone and thio-TEPA for meningeal involvement by malignancies.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613823

Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613823

Evaluation of 9-dimethylaminomethyl-10-hydroxycamptothecin against xenografts derived from adult and childhood solid tumors

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613823

Activity of topotecan, a new topoisomerase I inhibitor, against human tumor colony-forming units in vitro

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613823

Neoplastic meningitis-related encephalopathy: prognostic significance

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613823

An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613823

Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613823

A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors

4 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18316473

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18316473

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1215/15228517-2007-059

1 reference

17 August 2017

1 reference

17 August 2017

1 reference